
Why Pharma Should be Focusing on ESG
Learn more about how the pharma industry is taking charge to improve environmental, social, and governance (ESG) critical issues.
We value candid dialog and transparent communication. It goes without saying that we regularly inform our customers, shareholders and the public about the most important developments at our company. You can choose from different news types such as articles, events, webcasts and webinars, reports or ad-hoc announcements.
Learn more about how the pharma industry is taking charge to improve environmental, social, and governance (ESG) critical issues.
Datwyler is now focusing exclusively on system-critical elastomer components. The continuing operations generated record revenue and currency-adjusted growth of 15.0%.
With twelve focus topics, the company aims to reduce its environmental footprint and create added value for all stakeholders.
Despite the ongoing uncertainty caused by the pandemic, Datwyler has increased its forecasts for the year as a whole for revenue and EBIT margin to over CHF 1’150 million and above 16%, respectively.